To the Editor: I would like to apologize to the readers of JAMA for an incomplete financial disclosure in my article on reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations.1 My coauthor and I received no financial or material support of any kind from any entity for this study. In the article, we described the funding source and outcome for those cardiovascular trials surveyed in which I served as either the primary author or coauthor.2- 5